該雜志國(guó)際簡(jiǎn)稱:CHINESE MED J-PEKING,是由出版商Wolters Kluwer Medknow Publications出版的一本致力于發(fā)布醫(yī)學(xué)研究新成果的的專業(yè)學(xué)術(shù)期刊。該雜志以MEDICINE, GENERAL & INTERNAL研究為重點(diǎn),主要發(fā)表刊登有創(chuàng)見(jiàn)的學(xué)術(shù)論文文章、行業(yè)最新科研成果,扼要報(bào)道階段性研究成果和重要研究工作的最新進(jìn)展,選載對(duì)學(xué)科發(fā)展起指導(dǎo)作用的綜述與專論,促進(jìn)學(xué)術(shù)發(fā)展,為廣大讀者服務(wù)。該刊是一本國(guó)際優(yōu)秀雜志,在國(guó)際上有很高的學(xué)術(shù)影響力。
《Chinese Medical Journal》是一本以English為主的開(kāi)放獲取國(guó)際優(yōu)秀期刊,中文名稱中華醫(yī)學(xué)雜志,本刊主要出版、報(bào)道醫(yī)學(xué)-MEDICINE, GENERAL & INTERNAL領(lǐng)域的研究動(dòng)態(tài)以及在該領(lǐng)域取得的各方面的經(jīng)驗(yàn)和科研成果,介紹該領(lǐng)域有關(guān)本專業(yè)的最新進(jìn)展,探討行業(yè)發(fā)展的思路和方法,以促進(jìn)學(xué)術(shù)信息交流,提高行業(yè)發(fā)展。該刊已被國(guó)際權(quán)威數(shù)據(jù)庫(kù)SCIE收錄,為該領(lǐng)域相關(guān)學(xué)科的發(fā)展起到了良好的推動(dòng)作用,也得到了本專業(yè)人員的廣泛認(rèn)可。該刊最新影響因子為7.5,最新CiteScore 指數(shù)為9.8。
本刊近期中國(guó)學(xué)者發(fā)表的論文主要有:
High cut-off membranes in patients requiring renal replacement therapy: a systematic review and meta-analysis
Effectiveness and safety of Shexiang Baoxin Pill (MUSKARDIA) in patients with stable coronary artery disease and concomitant diabetes mellitus: a subgroup analysis of a randomized clinical trial
The Chinese Medical Journal (CMJ ) is published semimonthly in English by the Chinese Medical Association, and is a peer reviewed general medical journal for all doctors, researchers, and health workers regardless of their medical specialty or type of employment. Established in 1887, it is the oldest medical periodical in China and is distributed worldwide. The journal functions as a window into China’s medical sciences and reflects the advances and progress in China’s medical sciences and technology. It serves the objective of international academic exchange. The journal includes Original Articles, Editorial, Review Articles, Medical Progress, Brief Reports, Case Reports, Viewpoint, Clinical Exchange, Letter,and News,etc. CMJ is abstracted or indexed in many databases including Biological Abstracts, Chemical Abstracts, Index Medicus/Medline, Science Citation Index (SCI), Current Contents, Cancerlit, Health Plan & Administration, Embase, Social Scisearch, Aidsline, Toxline, Biocommercial Abstracts, Arts and Humanities Search, Nuclear Science Abstracts, Water Resources Abstracts, Cab Abstracts, Occupation Safety & Health, etc. In 2007, the impact factor of the journal by SCI is 0.636, and the total citation is 2315.
中科院SCI分區(qū)
Chinese Medical Journal雜志中科院分區(qū)信息
2023年12月升級(jí)版
綜述:否
TOP期刊:否
大類:醫(yī)學(xué) 3區(qū)
小類:
MEDICINE, GENERAL & INTERNAL 醫(yī)學(xué):內(nèi)科 3區(qū)
2022年12月升級(jí)版
綜述:否
TOP期刊:否
大類:醫(yī)學(xué) 2區(qū)
小類:
MEDICINE, GENERAL & INTERNAL 醫(yī)學(xué):內(nèi)科 2區(qū)
2021年12月舊的升級(jí)版
綜述:否
TOP期刊:否
大類:醫(yī)學(xué) 3區(qū)
小類:
MEDICINE, GENERAL & INTERNAL 醫(yī)學(xué):內(nèi)科 3區(qū)
2021年12月基礎(chǔ)版
綜述:否
TOP期刊:否
大類:醫(yī)學(xué) 3區(qū)
小類:
MEDICINE, GENERAL & INTERNAL 醫(yī)學(xué):內(nèi)科 3區(qū)
2021年12月升級(jí)版
綜述:否
TOP期刊:否
大類:醫(yī)學(xué) 3區(qū)
小類:
MEDICINE, GENERAL & INTERNAL 醫(yī)學(xué):內(nèi)科 3區(qū)
2020年12月舊的升級(jí)版
綜述:否
TOP期刊:否
大類:醫(yī)學(xué) 3區(qū)
小類:
MEDICINE, GENERAL & INTERNAL 醫(yī)學(xué):內(nèi)科 3區(qū)